The answer is hiding in carrier local coverage decisions
The Centers for Medicare and Medicaid Services is passing the buck on so many drug administration coding issues that getting familiar with your local carrier's policy is necessary.
In a new set of Frequently Asked Questions on drug administration codes, CMS says it's up to the Part B carriers to decide such tricky questions as:
The CMS decision to leave so much up to the carriers is a good one because it allows providers to petition their carriers directly for changes to policy, says consultant Chris Acevedo with Acevedo Consulting in Delray Beach, FL. He expects to see more local coverage determinations on drug administration soon.
"I just hope it doesn't result in a multitude of rules, so if you're dealing with carriers in different states you're going to have different rules to deal with," says coding expert Melanie Witt in Fredricksburg, VA.
Not paying for concurrent infusion with multiple drugs in one bag may make sense because "you're not sticking in the IV twice," notes Witt.
But Acevedo insists Medicare should cover concurrent drug administrations even for a single bag. The intent of the concurrent infusions code was "to pay you for that preparation and extra complexity of providing more than one drug," he notes. Even with one bag, preparing two drugs takes longer - and meanwhile the payments for the drugs themselves have dropped.
In the FAQ, CMS also clarifies that you can't bill for the chemotherapy demonstration project if you provide non-covered drugs or refill maintenance. You must provide chemotherapy with a cancer diagnosis, CMS insists.